首页> 外国专利> COMBINATIONS OF EDARAVON FOR THE TREATMENT OF ISCHEMIC BRAIN DAMAGE

COMBINATIONS OF EDARAVON FOR THE TREATMENT OF ISCHEMIC BRAIN DAMAGE

机译:依达拉奉联合治疗缺血性脑损伤

摘要

The present invention relates to a combination of edaravone with at least one substance selected from the group consisting of ebselen, resveratrol, uric acid, dehydroascorbic acid and disufenton sodium salt for the treatment of acute cerebrovascular accident (ACVI) - ischemic stroke in order to reduce neurological symptoms , disorders in the daily activities of the patient, as well as functional disorders of the central nervous system associated with stroke; amyotrophic lateral sclerosis (ALS) in order to slow the progression of functional disorders of the central nervous system; transient ischemic attack (TIA) in the acute period and after the attack; chronic cerebral ischemia; cognitive and behavioral disorders in vascular diseases of the brain.
机译:依达拉奉与至少一种选自依布硒仑,白藜芦醇,尿酸,脱氢抗坏血酸和二氟芬顿钠盐的组合物,用于治疗急性脑血管意外(ACVI)-缺血性中风神经系统症状,患者日常活动异常以及与中风有关的中枢神经系统功能异常;肌萎缩性侧索硬化症(ALS),以减缓中枢神经系统功能障碍的进展;急性期和发作后的短暂性脑缺血发作(TIA);慢性脑缺血脑血管疾病中的认知和行为障碍。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号